FDA.reportPublic FDA data

SPAREDI MINT AND EUCALYPTUS MASK

Manufacturer
CHEMCO CORPORATION
Effective date
2023-01-17
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:40:15

Label at a glance#

ProductSPAREDI MINT AND EUCALYPTUS MASK
Active ingredientBENZALKONIUM CHLORIDE
Label structure9 sections

Indications and uses

To decrease bacteria on the skin.

Dosage and administration

Apply a thin layer to cover the foot. Leave for 10 minutes, then rinse thoroughly with warm water.

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Benzalkonium chloride 0.1%

OTC - PURPOSE SECTION

Antibacterial

USES:

INDICATIONS & USAGE SECTION

To decrease bacteria on the skin.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Apply a thin layer to cover the foot. Leave for 10 minutes, then rinse
thoroughly with warm water.

WARNINGS SECTION

For external use only.

OTC - WHEN USING SECTION

•Keep out of eyes. In case of contact with eyes, rinse thoroughly
with water.• Do not apply to wounds or damaged skin.
•Do not apply to the irritated skin or if excessive irritation develops.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

INACTIVE INGREDIENT SECTION

Aqua, Cetyl Alcohol, Stearyl Alcohol, Methyl Salicylate, Eucalyptus Globulus Leaf Oil, DMDM Hydantoin, Methylparaben, Propylparaben, Mentha Piperita (Peppermint) Oil, Sodium Hyaluronate, Sodium PCA, Wheat Amino Acids, Panthenol, Symphytum Officinale (Comfrey) Extract, Hydroxyproline, Cetrimonium Chloride, Argania Spinosa Kernel Oil (Organic), Cocos Nucifera Oil (Organic), FD&C Yellow #5 (CI 19140), FD&C Blue #1 (Cl 42090).

SPAREDI - MINT AND EUCALYPTUS CREAM MASK 0.7 oz

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MINT CREAM MASK 07MINT CREAM MASK 07

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49283-101-072025-01-30C16284748780-12cef2736-61a4-d83d-e063-dadaa90ab31f49283-101-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49283-101SPAREDI MINT AND EUCALYPTUS MASK (BENZALKONIUM CHLORIDE) CREAM [CHEMCO CORPORATION]1Unmatched20230119_f27b4b75-ead7-5da0-e053-2a95a90ae155.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 23 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49283-10149283-101-07

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Name, UNII, Kind table
NameUNIIKind
CETRIMONIUM CHLORIDEUC9PE95IBPIACT
ARGANIA SPINOSA WHOLE83K6O4FR76IACT
EUCALYPTUS GLOBULUS LEAFS546YLW6E6IACT
MENTHA PIPERITA LEAFA389O33LX6IACT
CETYL ALCOHOL936JST6JCNIACT
SODIUM PYRROLIDONE CARBOXYLATE469OTG57A2IACT
COCOS NUCIFERA WHOLE245J88W96LIACT
WATER059QF0KO0RIACT
HYALURONATE SODIUMYSE9PPT4THIACT
METHYL SALICYLATELAV5U5022YIACT
METHYLPARABENA2I8C7HI9TIACT
BENZALKONIUM CHLORIDEF5UM2KM3W7ACTIB
STEARYL ALCOHOL2KR89I4H1YIACT
DMDM HYDANTOINBYR0546TOWIACT
PROPYLPARABENZ8IX2SC1OHIACT
PANTHENOLWV9CM0O67ZIACT
FD&C BLUE NO. 1H3R47K3TBDIACT
SODIUM COCOYL WHEAT AMINO ACIDSJW3VT57I11IACT
HYDROXYPROLINERMB44WO89XIACT
FD&C YELLOW NO. 5I753WB2F1MIACT
SYMPHYTUM OFFICINALE WHOLEH8FJJ6KX5YIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f27b3518-d5c3-1229-e053-2a95a90ab56ff27b4b75-ead7-5da0-e053-2a95a90ae1552023-01-17WarningsExact identifier
spl id: f27b3518-d5c3-1229-e053-2a95a90ab56f
spl set id: f27b4b75-ead7-5da0-e053-2a95a90ae155

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.